urea has been researched along with Hypertension, Malignant in 26 studies
pseudourea: clinical use; structure
isourea : A carboximidic acid that is the imidic acid tautomer of urea, H2NC(=NH)OH, and its hydrocarbyl derivatives.
Hypertension, Malignant: A condition of markedly elevated BLOOD PRESSURE with DIASTOLIC PRESSURE usually greater than 120 mm Hg. Malignant hypertension is characterized by widespread vascular damage, PAPILLEDEMA, retinopathy, HYPERTENSIVE ENCEPHALOPATHY, and renal dysfunction.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Although it has been reported that the circulating adrenomedullin (AM) level is elevated in hypertension and renal failure, the pathophysiological significance of circulating and intrarenal AM in malignant hypertension remains unknown." | 7.71 | Role of increased circulating and renal adrenomedullin in rats with malignant hypertension. ( Horio, T; Kanazawa, A; Kangawa, K; Matsuo, H; Matsuoka, H; Nagaya, N; Nishikimi, T; Okano, I; Yoshihara, F; Yutani, C, 2001) |
| "Treatment with intravenous and oral diazoxide was given to a group of 39 patients suffering from severe drug-resistant hypertension associated with renal impairment." | 7.65 | Use of diazoxide in hypertension with renal failure. ( Pohl, JE; Thurston, H, 1971) |
| "Although it has been reported that the circulating adrenomedullin (AM) level is elevated in hypertension and renal failure, the pathophysiological significance of circulating and intrarenal AM in malignant hypertension remains unknown." | 3.71 | Role of increased circulating and renal adrenomedullin in rats with malignant hypertension. ( Horio, T; Kanazawa, A; Kangawa, K; Matsuo, H; Matsuoka, H; Nagaya, N; Nishikimi, T; Okano, I; Yoshihara, F; Yutani, C, 2001) |
| " During the fourth to seventh week after the start of the experiment, malignant hypertension developed in most of the animals: body weight fell, reflecting volume depletion; serum osmolality and serum sodium and urea concentrations increased; in the kidneys malignant nephrosclerosis occurred." | 3.65 | Is vasopressin involved in the pathogenesis of malignant desoxycorticosterone hypertension in rats? ( Haack, D; Möhring, B; Möhring, J; Petri, M, 1976) |
| "During the onset of malignant hypertension (MH) in rats treated with deoxycorticosterone trimethylacetate (DOC), plasma arginine vasopressin (AVP) concentrations increase tenfold as a consequence of hypovolemia and hyperosmolality." | 3.65 | Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension. ( Haack, D; Möhring, B; Möhring, J; Petri, M, 1977) |
| "Treatment with intravenous and oral diazoxide was given to a group of 39 patients suffering from severe drug-resistant hypertension associated with renal impairment." | 3.65 | Use of diazoxide in hypertension with renal failure. ( Pohl, JE; Thurston, H, 1971) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 24 (92.31) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| ZOSIN, C | 1 |
| MANESCU, N | 1 |
| SCHWARTZKOPF, A | 1 |
| CLAURE, H | 1 |
| GARCIA, H | 1 |
| ACCHIARDO, S | 1 |
| Gibson, DG | 1 |
| Kazda, S | 1 |
| Garthoff, B | 1 |
| Dycka, J | 1 |
| Iwai, J | 1 |
| Lip, GY | 1 |
| Beevers, M | 1 |
| Beevers, DG | 2 |
| Nishikimi, T | 1 |
| Yoshihara, F | 1 |
| Kanazawa, A | 1 |
| Okano, I | 1 |
| Horio, T | 1 |
| Nagaya, N | 1 |
| Yutani, C | 1 |
| Matsuo, H | 1 |
| Matsuoka, H | 1 |
| Kangawa, K | 1 |
| Möhring, J | 2 |
| Möhring, B | 2 |
| Petri, M | 2 |
| Haack, D | 2 |
| Calich, NJ | 1 |
| dos Santos, MV | 1 |
| Prompt, CA | 1 |
| Costa, C | 1 |
| Franco, RJ | 1 |
| Matsubara, LS | 1 |
| Bonilha, JP | 1 |
| Mota, AC | 1 |
| Soares, VA | 1 |
| Habermann, F | 1 |
| Almeida, DB | 1 |
| Pogglitsch, H | 1 |
| Waller, J | 1 |
| Pristautz, H | 1 |
| Katschnigg, H | 1 |
| Garner, A | 1 |
| Ashton, N | 1 |
| Tripathi, R | 1 |
| Kohner, EM | 1 |
| Bulpitt, CJ | 1 |
| Dollery, CT | 1 |
| Brown, JJ | 2 |
| Ferriss, JB | 1 |
| Fraser, R | 1 |
| Lever, AF | 2 |
| Robertson, JI | 2 |
| Tree, M | 1 |
| Leary, WP | 1 |
| Asmal, AC | 1 |
| Naets, JP | 1 |
| Wittek, M | 1 |
| Williams, DM | 1 |
| Wimpenny, J | 1 |
| Asscher, AW | 1 |
| Genest, J | 1 |
| Boucher, R | 1 |
| Kuchel, O | 1 |
| Nowaczynski, W | 1 |
| Ferrario, CM | 1 |
| McCubbin, JW | 1 |
| Peart, WS | 1 |
| Olbing, H | 1 |
| Greifer, I | 1 |
| Bennett, BP | 1 |
| Bernstein, J | 1 |
| Spitzer, A | 1 |
| Wilkinson, JH | 1 |
| Pohl, JE | 1 |
| Thurston, H | 1 |
| Nolph, KD | 1 |
| Stoltz, ML | 1 |
| Maher, JF | 1 |
| Gavras, H | 1 |
| Brown, WC | 1 |
| Linton, AL | 1 |
| MacAdam, RF | 1 |
| McNicol, GP | 1 |
| Wardrop, C | 1 |
| Berlyne, GM | 1 |
| Gaan, D | 1 |
| Ginks, WR | 1 |
| Moyer, JH | 1 |
| Brest, AN | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Assessment of The Prevalence of Primary Aldosteronism in Hypertensive Patients Presenting With Atrial Flutter or Fibrillation[NCT01267747] | 411 participants (Actual) | Observational | 2015-01-31 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for urea and Hypertension, Malignant
| Article | Year |
|---|---|
Diagnostic significance of enzyme determinations in urine.
Topics: Acute Disease; Alkaline Phosphatase; Chronic Disease; Clinical Enzyme Tests; Cysts; Diabetes Mellitu | 1968 |
25 other studies available for urea and Hypertension, Malignant
| Article | Year |
|---|---|
[MALIGNANT ARTERIAL HYPERTENSION SYNDROME AND PYELONEPHRITIS].
Topics: Anti-Bacterial Agents; Antihypertensive Agents; Blood Chemical Analysis; Humans; Hypertension; Hyper | 1963 |
[EVOLUTION OF CHRONIC NEPHROPATHS WITH SEVERE OR MALIGNANT HYPERTENSION UNDER TREATMENT WITH GUANETHIDINE SULPHATE].
Topics: Adolescent; Cerebral Hemorrhage; Guanethidine; Hypertension; Hypertension, Malignant; Hypertension, | 1963 |
Abnormal splitting of the second heart sound in renal failure.
Topics: Adult; Bicarbonates; Blood Pressure; Glomerulonephritis; Heart; Hemoglobinometry; Humans; Hypertensi | 1967 |
Prevention of malignant hypertension in salt loaded "S" Dahl rats with the calcium antagonist nifedipine.
Topics: Animals; Blood Pressure; Creatinine; Female; Heart; Hypertension, Malignant; Muridae; Nifedipine; Or | 1982 |
Serum urate is associated with baseline renal dysfunction but not survival or deterioration in renal function in malignant phase hypertension.
Topics: Aged; Aging; Blood Pressure; Cause of Death; Creatinine; Female; Follow-Up Studies; Humans; Hyperten | 2000 |
Role of increased circulating and renal adrenomedullin in rats with malignant hypertension.
Topics: Adrenomedullin; Animals; Blood Pressure; Blotting, Northern; Body Weight; Calcitonin Receptor-Like P | 2001 |
Is vasopressin involved in the pathogenesis of malignant desoxycorticosterone hypertension in rats?
Topics: Angiotensin II; Animals; Antibodies; Arginine Vasopressin; Blood Pressure; Body Weight; Desoxycortic | 1976 |
[Malignant hypertension. Critical analysis of the treatment and prognosis in 18 cases].
Topics: Adult; Creatinine; Female; Humans; Hypertension, Malignant; Male; Middle Aged; Prognosis; Urea | 1979 |
[Malignant hypertension: clinical picture, treatment and evolution of 26 patients].
Topics: Adolescent; Adult; Antihypertensive Agents; Creatinine; Diuretics; Drug Therapy, Combination; Female | 1978 |
[Hemofiltration. Experiences with a new alternative treatment in terminal kidney failure].
Topics: Acid-Base Equilibrium; Cholesterol; Electrolytes; Humans; Hypertension, Malignant; Insulin; Insulin | 1978 |
Pathogenesis of hypertensive retinopathy. An experimental study in the monkey.
Topics: Animals; Arterial Occlusive Diseases; Basement Membrane; Blood Flow Velocity; Blood Pressure; Capill | 1975 |
Vasopressor role of ADH in the pathogenesis of malignant DOC hypertension.
Topics: Angiotensin II; Animals; Antibodies; Arginine Vasopressin; Blood Pressure; Body Weight; Desoxycortic | 1977 |
Renal abnormalities and vascular complications in primary hyperaldosteronism. Evidence on tertiary hyperaldosteronism.
Topics: Adenoma; Adrenal Gland Neoplasms; Adult; Aged; Female; Humans; Hyperaldosteronism; Hypertension, Mal | 1976 |
Plasma renin levels in Zulu hypertensives.
Topics: Black or African American; Black People; Female; Humans; Hypertension; Hypertension, Malignant; Hype | 1975 |
Erythropoiesis in anephric man.
Topics: Acute Disease; Adult; Anuria; Blood Cell Count; Blood Transfusion; Bone Marrow Examination; Erythrop | 1968 |
Renal clearance of sodium sulphadimidine in normal and uraemic subjects.
Topics: Adolescent; Adult; Chronic Disease; Diuresis; Female; Glomerular Filtration Rate; Glomerulonephritis | 1968 |
Renin in hypertension: how important as a risk factor?
Topics: Adult; Angiotensin II; Aortic Aneurysm; Aortic Rupture; Blood Pressure; Cerebrovascular Disorders; C | 1973 |
The unresolved nature of malignant hypertension.
Topics: Animals; Cardiac Output; Creatinine; Dogs; Hypertension, Malignant; Hypertension, Renal; Nitrogen; P | 1974 |
Results of medical versus surgical treatment of renovascular hypertension.
Topics: Adult; Age Factors; Creatinine; Female; Humans; Hypertension, Malignant; Hypertension, Renal; Male; | 1973 |
Idiopathic membranous nephropathy in children.
Topics: Adolescent; Age Factors; Aminohippuric Acids; Basement Membrane; Biopsy; Child; Child, Preschool; Cr | 1973 |
Use of diazoxide in hypertension with renal failure.
Topics: Adolescent; Adult; Blood Glucose; Creatine; Diazoxide; Dietary Proteins; Female; Humans; Hyperglycem | 1971 |
Altered peritoneal permeability in patients with systemic vasculitis.
Topics: Capillary Permeability; Creatinine; Diabetic Angiopathies; Diffusion; Epithelium; Humans; Hypertensi | 1971 |
Microangipathic hemolytic anemia and the development of the malignant phase of hypertension.
Topics: Adolescent; Adult; Anemia, Hemolytic; Blood Coagulation Disorders; Blood Pressure; Child, Preschool; | 1971 |
Dietary treatment of chronic renal failure.
Topics: Acidosis; Creatinine; Diet Therapy; Dietary Proteins; Glomerular Filtration Rate; Glomerulonephritis | 1968 |
The changing outlook for the patient with hypertension.
Topics: Antihypertensive Agents; Blood Urea Nitrogen; Humans; Hypertension; Hypertension, Malignant; Hyperte | 1966 |